Dr. Geoffrey Robert Nuss, MD

Dr. Nuss practices at Urology Partners of North Texas in Arlington, Texas.

Dr. Nuss' NPI, 1659575447, was assigned on June 13, 2007. Dr. Nuss graduated from Wake Forest School of Medicine in 2005. Dr. Nuss' Texas license number on file is M8219.

Dr. Nuss' primary practice is Urology Partners of North Texas, at 5005 S Cooper St, Arlington, TX 76017 in Tarrant County. The practice phone is (866) 367-8768.

Dr. Nuss' primary practice is Urology Partners of North Texas in Arlington, Texas. Dr. Nuss is also affiliated with Texas Health Arlington Memorial Hospital. The medical group on file is Urology Partners of North Texas. Dmand AI also links Dr. Nuss to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nuss practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Nuss' primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Nuss is board certified in urology by the American Board of Urology. Dmand AI has Dr. Nuss' licenses on file in 2 states: Texas and Illinois.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney stone disease, pelvic prolapse and prostate cancer among the conditions Dr. Nuss treats.

CMS data shows 5,358 Medicare services from Dr. Nuss across 39 procedure codes in 2024, for 637 Medicare patients. Medicare paid $244,313 for them.

CMS counts 637 Medicare patients who saw Dr. Nuss in 2024. The largest group is 75 to 84, with 279 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nuss' median patient age at 71, with 50% women.

In 2024, Dr. Nuss wrote 861 Medicare Part D claims for 301 patients. 77% of them were for generic drugs. CMS names the drug for 772 of them, across 17 drugs with 11 or more claims each, at $140,459 in total drug cost. In 2023, CMS named 676 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Nuss for performance year 2024, reported as part of a group. Dr. Nuss accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nuss as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Nuss, published from 2008 to 2016. The most frequent topics are Urinary Bladder Neoplasms and Urologic Surgical Procedures. Dr. Nuss has published most often in J Pediatr Urol. Dr. Nuss' most frequent co-authors are Yair Lotan, MD, Nicholas Glenn Cost, MD and Ganesh Venkataraman Raj, MD, PhD.

CMS Open Payments shows 518 general payments to Dr. Nuss from 49 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. Coloplast Corp paid the most, $4,546.

Dmand AI lists 1 award for Dr. Nuss, most recently CMS Stage 1 2012 in 2012.

Dr. Nuss graduated from Wake Forest School of Medicine in 2005.

Dr. Nuss is in network with 21 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.